Abstract
The periodicity of the menstrual cycle results from interactions among the hypothalamus, pituitary, ovaries, and genital tract. Each normal cycle culminates in menstrual bleeding, the first day of which is defined as the beginning of a menstrual cycle. The human menstrual cycle is divided into three phases: a follicular, or proliferative, phase; an ovulatory phase; and a luteal, or secretory, phase. The initiation of follicular growth begins during the late luteal phase of the preceding menstrual cycle, during which serum levels of progesterone (P) and estrogen (E2) decline, because of termination of the corpus luteum lifespan, and levels of FSH (follicle-stimulating hormone) rise. The rise in FSH initiates follicular development, which continues after the onset of menstrual bleeding. However, FSH then declines as a result of negative feed- back from the increasing E2 secreted by the granulosa cells of the growing follicle. During the follicular phase, E2 levels rise in parallel to the growth of the follicle and number of granulosa cells. LH levels increase at the midfollicular phase as a result of the positive feedback caused by increased E2 release. Just before ovulation, E2 secretion increases dramatically, which initiates the LH surge. LH promotes the process of luteinization of the granulosa cells and consequently enhances P secretion, which in turn facilitates the midcycle surge. After ovulation the remaining follicle undergoes striking changes resulting in the formation of the corpus luteum, which secretes a large amount of P and, to a lesser extent, E2. Accordingly, healthy young women exhibit different gonadal hormone milieus during the normal menstrual cycle, and such variations provide a model to investigate the impact of endogenously secreted estrogen and progesterone on GH secretion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hansen AP, Weeke J. Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles of oral contraceptives. Scand J Clin Lab Invest 1974;34:199–205.
Frantz AG, Rabkin MT. Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab 1965;25:1470–1480.
Merimee TJ, Fineberg SE, Tyson JE. Fluctuations of human growth hormone secretion during menstrual cycle: response to arginine. Metabolism 1969;18:606–608.
Genazzani AR, Lemarchand Beraud T, Aubert ML, Felber JP. Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle. J Clin Endocrinol Metab 1975;41:431–437.
Faria AC, Bekenstein LW, Booth RAJ, Vaccaro VA, Asplin CM, Veldhuis JD, Thorner MO, Evans WS. Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf) 1992;36:591–596.
Ovesen P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, Jorgensen JOL. Increased pulsatile but not basal growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. J Clin Endocrinol Metab 1998;83(5):1662–1667.
Zadik Z, Chalew SA, McCarter RJJ, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985;60:513–516.
Hoist N, Jenssen TG, Burhol PG, Haug E, Forsdahl F. Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles. J Clin Endocrinol Metab 1989;68:1160–1166.
Stone BA, Marrs RP. Growth hormone in serum of women during the menstrual cycle and during controlled ovarian hyperstimulation. Fertil Steril 1991;56:52–58.
Evans WS, Borges JL, Vance ML, Kaiser DL, Rogol AD, Furlanetto R, Rivier J, Vale W, Thorner MO. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle. J Clin Endocrinol Metab 1984;59:1006–1010.
Gelato MC, Pescovitz OH, Cassorla F, Loriaux DL, Merriam GR. Dose-response relationships for the effects of growth hormone-releasing factor-( 1-44)-NH2 in young adult men and women. J Clin Endocrinol Metab 1984;59:197–201.
Wang HS, Lee JD, Soong YK. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and-3 in women with regular menstrual cycles. Fertil Steril 1995;63:1204–1209.
Van Dessel HJHMT, Chandrasekher Y, Yap OWS, Lee PDK, Hintz RL, Faessen GHJ, Braat DDM, Fauser BCJM, Giudice LC. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and-3 during the normal menstrual cycle. J Clin Endocrinol Metab 1996;81:1224–1231.
Klein NA, Battaglia DE, Miller PB, Soules MR. Circulating levels of growth hormone, insulin-like growth factor-I and growth hormone binding protein in normal women of advanced reproductive age. Clin Endocrinol (Oxf) 1996;44:285–292.
Albertsson Wikland K, Rosberg S, Karlberg J, Groth T. Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab 1994;78:1195–1201.
Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72:374–381.
Friend EF, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women— a clinical research center study. J Clin Endocrinol Metab 1996;81:2250–2256.
Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51–58.
Massa G, Igout A, Rombauts L, Frankenne F, Vanderschueren Lodeweyckx M. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women. Clin Endocrinol (Oxf) 1993;39:569–575.
Vahl N, Jorgensen JOL, Jurik AG, Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age-associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab 1996;81:2209–2215.
Vahl N, Jorgensen JOL, Skjaerbaeck C, Veldhuis JD, Orskov H, Christiansen JS. Abdominal adiposity rather than age and sex predicts the mass and patterned regularity of growth hormone secretion in mid-life healthy adults. Am J Physiol 1997;272:E1108–1116
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ovesen, P., Vahl, N., Christiansen, J.S., Veldhuis, J.D., Jorgensen, J.O.L. (1999). Menstrual Cycle Interaction with the Growth Hormone Axis. In: Veldhuis, J.D., Giustina, A. (eds) Sex-Steroid Interactions with Growth Hormone. Proceedings in the Serono Symposia USA Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1546-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1546-2_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-98810-8
Online ISBN: 978-1-4612-1546-2
eBook Packages: Springer Book Archive